Qing Hao, MD, PhD
- ASSISTANT PROFESSOR | Neurology
- Chinese (Mandarin)
- Chinese (Cantonese)
- Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Queens
- Stroke Center 212-241-7076 212-241-7076
Dr. Qing Hao is an Assistant Professor of Neurology and the Medical Director of the Thrombectomy-capable Stroke Center at Mount Sinai Queens.
Dr. Hao received her medical degree from Peking University Health Science Center in China. She then received research training at the Chinese University of Hong Kong where she received her Ph.D. degree. She continued stroke research in UCLA Stroke Center before she joined SUNY Downstate Medical Center for internship and neurology residency training. Upon completion of vascular neurology fellowship in Johns Hopkins University School of Medicine, she returned to New York and joined Mount Sinai Health System Department of Neurology. Dr. Hao takes care of patients with stroke and cerebral vascular disease at Mount Sinai Hospital and Mount Sinai Queens.
Dr. Hao‘s research interests include exploring the pathophysiological mechanisms of atherosclerotic disease and ischemic stroke using different imaging modalities, including transcranial Doppler ultrasound, magnetic resonance imaging including ultrahigh field MRI, computed tomography angiography/perfusion, with the goal of optimizing stroke treatment and stroke prevention to improve the outcomes. She has published 30+ peers review articles and serves as a reviewer for several scientific journals.
Dr. Hao offers telemedicine appointments when appropriate. Please call her office to schedule a video visit.
Dr. Hao is registered to provide telehealth services in Florida.
Neurology, American Board of Psychiatry and Neurology
Atherosclerosis, Magnetic Resonance Imaging, Stroke
MD, Peking University Health Sciences Center
PhD, The Chinese University of Hong Kong
SUNY Downstate Medical Center
Fellowship, Vascular Neurology
Johns Hopkins Hospital
Chinese (Mandarin), Chinese (Cantonese), English
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Hao did not report having any of the following types of financial relationships with industry during 2021 and/or 2022: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.